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Outﬂow tract (OFT) anomalies are among the most common congenital heart defects found at birth. The
embryonic OFT grows by the progressive addition of cardiac progenitors, termed the second heart ﬁeld
(SHF), which originate from splanchnic pharyngeal mesoderm. Development of the SHF is controlled by
multiple intercellular signals and transcription factors; however the relationship between different SHF
regulators remains unclear. We have recently shown that Hoxa1 and Hoxb1 are expressed in a sub-
population of the SHF contributing to the OFT. Here, we report that Hoxb1 deﬁciency results in a shorter
OFT and ventricular septal defects (VSD). Mechanistically, we show that both FGF/ERK and BMP/SMAD
signaling, which regulate proliferation and differentiation of cardiac progenitor cells and OFT morpho-
genesis, are enhanced in the pharyngeal region in Hoxb1 mutants. Absence of Hoxb1 also perturbed SHF
development through premature myocardial differentiation. Hence, the positioning and remodeling of
the mutant OFT is disrupted. Hoxa1 / embryos, in contrast, have low percentage of VSD and normal
SHF development. However, compound Hoxa1 /; Hoxb1þ / embryos display OFT defects associated
with premature SHF differentiation, demonstrating redundant roles of these factors during OFT devel-
opment. Our ﬁndings provide new insights into the gene regulatory network controlling SHF and OFT
formation.
& 2015 Elsevier Inc. All rights reserved.1. Introduction
Congenital heart defects (CHD) are the most common class of
birth defect (Hoffman and Kaplan, 2002). Approximately one-third
of CHD involve malformations of the conotruncal region (also
known as the outﬂow tract [OFT]), which gives rise to the con-
nection between the ventricles and the great vessels. Elongation of
the OFT is a prerequisite for correct cardiac looping as well as
rotation and proper alignment of the ventricles and great vessels
during aortico-pulmonary septation. In the early embryo, the heart
tube elongates by addition of cardiac progenitor cells lying outside
the heart itself. The source of the new myocardium is alté de Médecine, 27 bd Jean
.
Zaffran).
t de Recherches Cliniques de
8, Campus de Luminy, Mar-mesodermal progenitor cell population situated in splanchnic
pharyngeal mesoderm termed the second heart ﬁeld (SHF) (see
Buckingham et al., 2005; Vincent and Buckingham, 2010; Zaffran
and Kelly, 2012). Progressive addition of these cells to the cardiac
poles accompanies rightward looping and heart tube elongation.
During this process, SHF cells in pharyngeal mesoderm are closely
apposed to cardiac neural crest cells and pharyngeal endoderm.
The progressive elongation of the OFT is regulated by multiple
intercellular signals and transcription factors in the pharyngeal
mesoderm and adjacent cell types including pharyngeal epithelia
and neural crest-derived cells (Rochais et al., 2009; Zaffran and
Kelly, 2012). Direct or indirect perturbations of the SHF and/or
cardiac neural crest cells are associated with OFT alignment de-
fects such as double outlet right ventricle (DORV) and ventricular
septal defects (VSD) (Cai et al., 2003; Kirby et al., 1983; Park et al.,
2006; Porras and Brown, 2008; Prall et al., 2007; Ward et al.,
2005). Hence, the identiﬁcation and characterization of regulatory
networks operating during OFT formation is essential to under-
stand the origin(s) of CHD.
The contribution of the SHF to the heart has been followed
Table I
Cardiac defects in single and compound Hoxa1; Hoxb1 mutant mice.
Genotype n Alignment defects DORV VSD
Wild-type 38 – –
Hoxb1þ / 28 – –
Hoxb1 / 28 7% 21%
Hoxa1þ / 34 – –
Hoxa1 / 27 – 11%
Hoxa1þ / Hoxb1þ / 24 – –
Hoxa1þ / Hoxb1 / 12 – 25%
Hoxa1 / Hoxb1þ /- 11 – 18% 18%
Hoxa1 / Hoxb1 / 3 – 67% 67%
VSD, ventricular septal defect. DORV, double outlet right ventricle.
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yngeal mesoderm (Cai et al., 2003; Sun et al., 2007). There is in-
creasing evidence for the existence of sub-domains in the SHF,
distinguishable by gene expression and their contribution to the
heart (see Vincent and Buckingham, 2010 and Zaffran and Kelly,
2012). Gene expression and cell labeling experiments have shown
that the anterior part of the SHF (aSHF, or anterior heart ﬁeld),
which expresses Fibroblast growth factor (Fgf8) and the Mlc1v-
nlacZ-24 (Fgf10-nlacZ) transgene (Kelly et al., 2001), is pro-
grammed to make OFT and right ventricular myocardium (Zaffran
et al., 2004). In contrast, the posterior part of the SHF (pSHF)
containing Isl1-positive but Fgf10-nlacZ-negative cells (Galli et al.,
2008), contributes to both the inﬂow and outﬂow cardiac regions
(Bertrand et al., 2011; Dominguez et al., 2012). We previously re-
ported that the anterior Hox genes Hoxa1, Hoxa3 and Hoxb1 are
expressed in distinct sub-domains of the pSHF that contribute to
the venous pole and the inferior wall of OFT myocardium, which
subsequently gives rise to myocardium at the base of the pul-
monary trunk or sub-pulmonary myocardium (Bertrand et al.,
2011). Consistent with these observations, recent fate mapping
and clonal analyzes experiments have conﬁrmed that pSHF cells
contribute to OFT myocardium and that sub-pulmonary and inﬂow
tract myocardium are clonally related (Dominguez et al., 2012;
Lescroart et al., 2012).
Hox genes encode a class of transcription factors that play an
important role in patterning vertebrate axial development (Mallo
et al., 2010; Wellik, 2009). Hox genes have been shown to respond
to retinoic acid (RA), the active derivative of vitamin A, during
early embryonic development (Duester, 2008; Niederreither and
Dolle, 2008; Niederreither et al., 1999). Retinaldehyde dehy-
drogenase 2 (Raldh2) mutant embryos, which are severely im-
paired in their capacity to synthesize RA, develop abnormal hearts
with a single ventricular chamber and highly hypoplastic sinus
venosus region (Niederreither et al., 1999, 2001). Our previous
work performed on Raldh2 / null embryos has implicated the
SHF as the main cardiac progenitor population affected by RA
deﬁciency (Ryckebusch et al., 2008). In addition, manipulation of
RA level and identiﬁcation of a RA-response element in the Hoxa3
promoter demonstrated that expression of anterior Hox genes in
the pSHF and pharyngeal endoderm is directly dependent on RA
signals (Bertrand et al., 2011; Diman et al., 2011). Hoxa1 has since
been shown to be required for cardiovascular development (Makki
and Capecchi, 2012). Makki and Capecchi (2012) demonstrated
that the expression of Hoxa1 in precursors of cardiac neural crest
cells is important for speciﬁcation of these cells that contribute to
great artery and OFT formation. Several Hoxb1 mutant mouse
models have been generated and analyzed (Gaufo et al., 2000;
Goddard et al., 1996; Studer et al., 1996). Although Hoxb1-null
mice die neonatally with facial nerve and muscle defects, cardiac
anomalies have not been reported (Gaufo et al., 2000; Goddard
et al., 1996; Studer et al., 1996). Therefore, the role of anterior Hox
genes during heart development remains unclear.
Here we show that Hoxb1 acts in the pharyngeal region to
prevent premature differentiation of the OFT myocardium from
cardiac progenitors by regulating both FGF and BMP signaling.
In addition, we demonstrate that loss of Hoxa1 function does not
affect SHF development. However, using compound mutant mice,
we reveal that Hoxa1 and Hoxb1 act redundantly to prevent pre-
mature differentiation of cardiac progenitors contributing to the
OFT. Our work identiﬁes a novel role for anterior Hox genes in
cardiac progenitor cells that contribute to the formation of the
conotruncal (OFT) region.2. Material and methods
2.1. Mice
All mouse experiments were carried out using protocols ap-
proved by the “comité d’éthique pour l’expérimentation animale”
(Marseille ethical committee, Protocol no. 32– 08,102,012). The
null alleles of Hoxa1neo and Hoxb1GFP (hereafter referred to as
Hoxa1 and Hoxb1) have been already described (Gaufo et al.,
2000; Lufkin et al., 1991). To avoid strain background effects, we
crossed mice onto the C57BL/6 background. All genotypes were
observed at the expected Mendelian ratios (Supplementary ma-
terial, Table S1). Double heterozygous Hoxa1þ /;Hoxb1þ / mice
were interbred to obtain Hoxa1 /; Hoxb1 / embryos (Table I).
Hoxb1IRES-Cre knock-in mouse line and Mlc1v-nlacZ-24, y96-Myf5-
nlacZ-16 (96-16), Mef2c-AHF-Cre, and Rosa26LacZ transgenic lines
have been previously described (Arenkiel et al., 2003; Bajolle et al.,
2006; Bertrand et al., 2011; Kelly et al., 2001; Li and Lufkin, 2000;
Soriano, 1999; Verzi et al., 2005). Mice were genotyped by PCR and
embryos staged taking the morning of the vaginal plug as em-
bryonic day (E) 0.5.
2.2. RNA in situ hybridization and X-gal staining
To visualize β-galactosidase activity, embryos or hearts were
isolated, ﬁxed in 4% paraformaldehyde for 20 min and incubated in
X-gal solution, according to standard procedures. Embryos and
hearts were photographed (Zeiss Axiozoom) as whole mount
specimens and then embedded in O.C.T. and cut into 12 mm his-
tological section before counterstaining with eosin.
Whole-mount in situ hybridization (WISH) was performed as
previously described (Ryckebusch et al., 2010). The riboprobes
used in this study were crabp1, Mlc2v, Tbx1, Islet1, Fgf8, Bmp4, and
Shh. For WISH, hybridization signals were detected by alkaline
phosphatase (AP)-conjugated anti-DIG antibodies (1/2000;
Roche), followed by color development with NBT/BCIP (magenta)
substrate (Promega). After staining, the samples were washed in
PBS and post-ﬁxed. Embryos were photographed using a Zeiss
Axiozoom microscope coupled to an Axiocam digital camera
(AxioVision 4.4, Zeiss). Three or more embryos were examined for
all conditions.
2.3. Histology and Immunochemistry
Standard histological procedures were used (Ryckebusch et al.,
2010). Whole mount specimens were embedded in OCT and cut at
12 μm per tissue section. α-actinin (1:500, Sigma), AP-2α (1:50,
DSHB), β-galactosidase (1:500, Cappel), Caspase3 (1:300, Cell
signal), GFP (1:500; Invitrogen), Islet1 (1:100, DSHB), MF20 (1:100,
DSHB), phospho-extracellular signal regulated kinase (phosphor-
ERK) (1:100, Cell Signaling), Phospho-histone H3 (p-HH3) (1:400,
Fig. 1. Impaired development of OFT in Hoxb1 / embryos. (A) and (B) Hematoxylin & eosin (H&E) stained sections of E16.5 wild-type (WT) and Hoxb1 / hearts. Ven-
tricular septal defects (VSD) are observed in Hoxb1 / embryos (B; asterisk). (C) and (D) Frontal view of E16.5 hearts showing misalignment of the great vessels in Hoxb1 /
embryos. (E) and (F) Histological sections showing abnormal position of the aorta in Hoxb1–/– compared toWT embryos. (G) and (H) Whole-mount RNA in situ hybridization
for Mlc2v (myosin light chain 2 v). Morphology of the OFT appears abnormal in Hoxb1–/– heart compared to WT heart. (I) and (J) Histological sections of WT and Hoxb1 /
embryos showing abnormal distribution of Mlc2v expression in the distal OFT (arrowhead). (K) and (L) Histograms showing OFT length measurements and the angle
between the proximal and distal region of the OFT fromWT (n¼9) and Hoxb1 / (n¼13) hearts at E10.5 (*p¼0.0001, Student’s t test). (M)–(P) Ventral views of X-gal stained
hearts fromWT (M,O) and Hoxb1 / (N,P) embryos carrying the y96-Myf5-nlacZ-16 (96-16) transgene at E10.5 (M,N) and E15.5 (O,P). X-gal straining reveals reduction of 96-
16 transgene expression in Hoxb1 / (N; brackets) compared to WT hearts. At E15.5, β-gal positive cells are less abundant at the base of the pulmonary trunk of Hoxb1 /
(P) compared to WT (O) hearts (arrows). Histograms are expressed as mean 7SEM. A, atrium; Ao, aorta; LA, left atrium; LV, left ventricle; OFT, outﬂow tract; pt, pulmonary
trunk; RA, right atrium; RV, right ventricle.
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histochemistry were performed using 4% paraformaldehyde ﬁxed
tissue and Alexa ﬂuorescent-conjugated secondary antibodies (Life
Technologies) were used at 1:500.
2.4. Quantitative RT-PCR
The pharyngeal region, including ventral pharyngeal meso-
derm and endoderm, from embryos at E9.5 were dissected in cold1XPBS. All embryos were genotyped by PCR using yolk sac DNA.
Total RNA was isolated using NucleoSpin RNA kit (Macherey-Na-
gel). Reverse transcriptions was performed using ﬁrst strand cDNA
kit (Roche). LightCycler 480 SYBR Green I Master mix (Roche) was
used for quantitative real-time qRT-PCR analysis with a LightCycler
480 (Roche). Gene-speciﬁc primers used in this study were,
Fgf8-For: 5′-tggaagcagagtccgagttc and Fgf8-Rev: 5′-tgtgaa-
tacgcagtccttgc; ATP50-For: 5′-ctatgcaaccgccctgtact and ATP50-
Rev: 5′-gatgataccctgggtgttgc; Bmp4-For: 5′-acaccaagcaatagccctaag
M. Roux et al. / Developmental Biology 406 (2015) 247–258250and Bmp4-Rev: 5′ggagactcattcccacctttg. Each experiment was
performed in triplicate for each genotype. Samples were normal-
ized to transcript levels of ATP50 gene. Transcript level changes
were calculated by the comparative cycle threshold (ΔΔCT)
method. Normalized expression levels in the control (Hoxb1þ /þ)
were set to 1.0 for each gene.
2.5. Measurement of OFT length and angle
In situ hybridization with a Mlc2v riboprobe was performed on
E10.5 embryos. Embryos were photographed using a Zeiss Ax-
iozoom microscope coupled to an Axiocam digital camera (Ax-
ioVision 4.4, Zeiss). Ventral view images were taken from the same
angle. The expression of Mlc2v was used to delimit the proximal
OFT and to measure the length of the OFT. Measurement of OFT
angle was made as follow: The right ventricle was encircled and
the center of the circle was used as a landmark to draw a line
through the middle of the proximal OFT. The OFT angle was
measured at the intersection between this line and a second line
passing through the middle of the distal OFT.
2.6. Statistical analysis
Statistics were carried out using Fischer’s exact probability test,
Χ2 test for two independent samples and Student’s t test to
compare variances.3. Results
3.1. Hoxb1 is required for cardiac OFT development
We have recently demonstrated that Hoxb1 is expressed in a
sub-population of second heart ﬁeld (SHF) cardiac progenitor cells
located in splanchnic pharyngeal mesoderm (Bertrand et al., 2011).
At embryonic day (E) 9.5, double immunostaining conﬁrmed that
Hoxb1 is expressed in SHF progenitors and pharyngeal endoderm
where Islet1 (Isl1) is expressed (Supplemental Fig. S1). To de-
termine if Hoxb1 deletion was deleterious for heart development,
we intercrossed Hoxb1þ / mice and collected embryos at E16.5.
All wild-type (WT, n¼38) and Hoxb1þ / (n¼28) fetuses had
normal cardiac morphogenesis. However, we found that six out of
28 (21%) Hoxb1 mutants had membranous ventricular septal de-
fects (VSD) (Fig. 1A and B and Table I) and 7% (2/28) exhibited
abnormal position of the great vessels (Fig. 1C–F). These results
reveal cardiac defects in absence of Hoxb1. Of note, although we
have shown that Hoxb1-expressing cells also contribute to the
inﬂow region of the heart (Bertrand et al., 2011), our morpholo-
gical examination revealed no inﬂow tract or atrioventricular canal
defects in these mutants, suggesting a functional redundancy be-
tween paralogous Hox expressed in pSHF cells (Bertrand et al.,
2011).
The origin of the observed defects was analyzed by examining
Hoxb1 / embryos at earlier stages of cardiac development. In
order to visualize the morphology of the OFT, whole-mount and
section RNA in situ hybridizations were performed on WT and
Hoxb1 / embryos with amyosin light chain 2v (Mlc2v), which has
differential expression levels in the proximal and distal regions of
OFT myocardium (Zammit et al., 2000) (Fig. 1G–L). Expression of
Mlc2v was abnormally detected in the distal OFT in Hoxb1-/- em-
bryos (Fig. 1G-J; arrowhead). Consistent with these observations,
OFT length was signiﬁcantly reduced in Hoxb1 / (n¼13) com-
pared to WT (n¼9) littermates (p¼0.0001; Fig. 1K). However,
there was no difference in the angle between the proximal and
distal regions of mutants OFT (p¼0.12; Fig. 1L). Our previous study
showed that SHF Hoxb1-expressing cells contribute to the inferiormyocardial wall of the OFT (Bertrand et al., 2011). In order to vi-
sualize this sub-domain of the OFT, Hoxb1þ / mice were inter-
crossed with y96-Myf5-nlacZ-16 (96-16) transgenic mice, in which
β-galactosidase (β-gal) activity is observed in myocardial cells of
the inferior OFT wall (Bajolle et al., 2006). At E10.5, X-gal staining
revealed a reduction in the number of myocardial cells expressing
β-gal in the OFT of Hoxb1 / embryos (Fig. 1M and N). We found
that the sub-domain of the OFT expressing the 96-16 transgene
appeared to be shorter in Hoxb1 / compared to WT embryos
(Supplemental Fig. S2). At E15.5, 96-16 transgene expression is
typically detected in the myocardium at the base of the pulmonary
trunk of WT hearts (Fig. 1O) (Bajolle et al., 2006). Consistent with
our observations at E10.5, less X-gal-positive cells were observed
at the base of the pulmonary trunk of Hoxb1 / hearts (Fig. 1P).
These ﬁndings demonstrate that the Hoxb1 / OFT is abnormal,
and that the inferior OFT wall, which originates from the pSHF, is
primarily affected.
3.2. Loss of Hoxb1 affects FGF signaling in the pharyngeal region
Since OFT defects in Hoxb1 mutants are consistent with a SHF
anomaly (Ward et al., 2005), we assessed the role of Hoxb1 in SHF
development. We ﬁrst examined the expression of a gene ex-
pressed throughout the SHF, Islet (Isl1) (Cai et al., 2003). Isl1
transcripts were normally expressed in the SHF of Hoxb1 / em-
bryos (data not shown) and Isl1 protein was observed in phar-
yngeal mesoderm and the distal OFT of Hoxb1 / embryos (Sup-
plemental Fig. S3). The T-box gene Tbx1, genetically upstream of
Fgf10 and Fgf8 (Abu-Issa et al., 2002; Frank et al., 2002; Vitelli
et al., 2002), also displayed normal expression in the pharyngeal
region of Hoxb1 / embryos (Supplemental Fig. S3). In addition,
expression of the Mlc1v-nlacZ-24 (Fgf10-nlacZ) transgene, whose
integration site upstream of Fgf10 locus results in transcriptional
activation of the transgene in pharyngeal mesoderm (Kelly et al.,
2001), exhibited no obvious alteration in Hoxb1 / embryos
(Supplemental Fig. S3). Consistent with this, activity ofMef2c-AHF-
Cre transgene, expressed in the aSHF (Verzi et al., 2005), was in-
distinguishable in Hoxb1 / compared to control littermates
(Supplemental Fig. S3).
We subsequently investigated FGF signaling, which is known to
regulate the contribution of SHF-derived cells to the developing
OFT. Fgf8 transcripts, which are normally expressed in the lateral
pharyngeal endoderm, surface ectoderm and, at low level, in lat-
eral pharyngeal mesoderm (Fig. 2A and C) (Ilagan et al., 2006;
Kelly et al., 2001), accumulated abnormally in ventral pharyngeal
mesoderm in the dorsal pericardial wall of Hoxb1 / embryos
(Fig. 2B and D). Quantitative real-time (qRT)-PCR using tissue
isolated from anterior pharyngeal regions at E9.5 conﬁrmed an up-
regulation of Fgf8 transcript levels in Hoxb1 / compared to
control embryos (Fig. 2E). In order to analyze the extent of FGF
signaling in normal expression in the pharyngeal region embryos,
we performed immunostaining for phosphorylated ERK1/2 (p-
ERK), kinase effectors of the MAP signaling pathway whose
phosphorylation correlates with the activity of FGF8 in early heart
development (Corson et al., 2003; Ilagan et al., 2006). At E9.5,
when p-ERK staining is normally absent in pharyngeal mesoderm
(Fig. 2F) (Ilagan et al., 2006), an increased number of p-ERK-po-
sitive cells was observed in the dorsal pericardial wall of Hoxb1 /
embryos (Fig. 2G–I), consistent with elevated FGF signaling. To
investigate whether activation of FGF signaling results in elevated
cell division we performed immunostaining for phosphorylated
histone H3 (p-HH3), a mitotic maker. We found that the mitotic
index of SHF cardiac progenitor cells (Isl1 and p-HH3 double po-
sitive cells) in Hoxb1 mutant embryos (n¼4) was signiﬁcantly
increased (40%; po0.05) compared toWT embryos (n¼4) (Fig. 2J–
M). The number of p-HH3-positive cells was also increased in the
Fig. 2. Absence of Hoxb1 disrupts FGF/ERK signaling and increases proliferation in foregut endoderm and SHF mesoderm. (A)–(D) Whole-mount in situ hybridization (A) and
(B) and corresponding transverse sections (C) and (D) showing ectopic Fgf8 expression in the pharyngeal mesoderm (or dorsal pericardial wall) of Hoxb1 / embryos (arrow)
at E9.5. (E) Real-time qPCR was performed from isolated pharyngeal region of E9.5 Hoxb1 / and wild-type (WT) embryos. This analysis demonstrates signiﬁcantly increased
levels of Fgf8 gene in Hoxb1 / vs. WT embryos. (F) and (G) Immunochemistry with anti-phospho-ERK antibody (p-ERK, green) in transverse sections through the caudal
pharyngeal region of E9.5 WT and Hoxb1 / embryos. Note the increased number of p-ERK positive cells in the ventral pharyngeal mesoderm and endoderm of Hoxb1 /
(arrows). (H) and (I) Histograms comparing the number of p-ERK-positive cells per section (n¼8) in the pharyngeal mesoderm (H) and foregut endoderm (I) of WT (n¼3)
and Hoxb1 / (n¼3) embryos. An increase in p-ERK-positive cells is observed in Hoxb1 / pharyngeal mesoderm and endoderm (*po0.05, Student’s t test). (J) and
(K) Immunochemistry with anti-phospho-Histone H3 (p-HH3, green) and anti-Isl1 (Isl1, red) antibodies in transverse sections of E9.5 WT and Hoxb1 /embryos; arrows
points to Isl1/pHH3 double-positive cells in both pharyngeal mesoderm and endoderm. (L) and (M) Histograms comparing the mitotic index in the pharyngeal mesoderm
(L) and foregut endoderm (M) of WT and mutants at 9.5. An increase of the mitotic index is observed in both pharyngeal mesoderm and endoderm (**po0.05; *po0.02,
Student’s t test). (N) and (O) Immunochemistry with anti-AP-2α antibody (red) in transverse sections of E9.5 embryos showing presence of neural crest-derived mesenchyme
in Hoxb1 / embryos. Nuclei are labeled with DAPI (blue). Histograms are expressed as mean 7SEM. ba, branchial arch; dpw, dorsal pericardial wall;; L-end, lateral
pharyngeal endoderm; mes, pharyngeal mesenchyme; OFT, outﬂow tract; Ph, pharynx; RV, right ventricle; se, surface ectoderm; V-end, ventral pharyngeal endoderm.
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(Fig. 2L and M; po0.04), suggesting persistence of active FGF
signal in this layer after E9 in the absence of Hoxb1. We also ex-
amined apoptosis of the cardiac progenitor cells by performing
immunostaining for cleaved Caspase 3. We found equivalent low
numbers of Caspase 3-positive cells in the pharyngeal region of
Hoxb1 / and WT embryos, suggesting that apoptosis levels are
unaltered (data not shown).
It has been shown that FGF8 signaling is elevated after neural
crest ablation in chick embryos (Waldo et al., 2005a, Huston et al.,
2006). To evaluate potential changes in the number of neural
crest-derived mesenchymal cells in the pharyngeal region of
Hoxb1 mutant embryos, we examined the expression of AP-2α, a
marker of migrating neural crest cells. Immunostaining for AP-2αshowed that neural crest-derived cells appeared normal in num-
ber and were located in direct apposition to SHF cells and they
(Fig. 2N and O).
3.3. Deletion of Hoxb1 results in premature differentiation of cardiac
progenitors
It has previously been demonstrated that BMP-SMAD1 signal-
ing induces cardiac differentiation during OFT elongation and an-
tagonizes FGF signals (Dyer and Kirby, 2009; Hutson et al., 2010;
Prall et al., 2007; Tirosh-Finkel et al., 2010; Wang et al., 2010).
Therefore, we examined the expression of Bmp4, known to be
crucial during OFT development (Liu et al., 2004). Although, in situ
hybridization suggested a slight increase of Bmp4 expression in the
Fig. 3. Loss of Hoxb1 induces premature differentiation of SHF progenitor cells. (A) and (B) RNA in situ hybridization analysis of Bmp4 in Hoxb1 / and wild-type (WT)
embryos at E9.5. (C) and (D) Immunochemistry with anti-phospho-Smad1/5/8 antibody (p-Smad1, green) in transverse sections of E9.5 embryos reveals increased p-Smad1
expression in the ventral endoderm of mutant embryos (arrows). (E) and (F) Histograms comparing the number of p-Smad1-positive cells per section (n¼8) in the
pharyngeal endoderm (E) and the dorsal pericardial wall (dpw, F) of E9.5 WT (n¼3) and Hoxb1/ (n¼3) embryos. Note the increased number of p-Smad1-positive cells in
the foregut endoderm (*po0.05, Student’s t test). (G)–(J) Sagittal sections ofWT and Hoxb1/ embryos at E9.5 labeled with anti-α-actinin (G) and (H) and anti-MF20 (I) and
(J). Note the expression of differentiated cardiomyocytes in the SHF caudally to the outﬂow tract in Hoxb1 / embryos (arrows). (K) and (L) Three-dimensional re-
constructions of the dorsal pericardial wall show an increased number of MF20-positive cells in Hoxb1 / embryos. Nuclei are labeled with DAPI (blue). Histograms are
expressed as mean 7SEM. A, anterior; AS, aortic sac; L-end, lateral pharyngeal endoderm; mes, pharyngeal mesenchyme; OFT, outﬂow tract; P, posterior; ph, pharynx; RA,
right atrium; RV, right ventricle; se, surface ectoderm; V-end, ventral pharyngeal endoderm.
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tative RT-PCR analysis did not conﬁrm such difference (data not
shown). However, elevated phospho-Smad1/5/8 (p-Smad1) label-
ing was observed in the ventral endoderm of Hoxb1 null mutants
(Fig. 3C–F). Another marker of ventral pharyngeal endoderm, Shh,
required for SHF development, was present at normal levels in the
ventral foregut of Hoxb1 mutant embryos (Supplemental Fig. S4).
At E9.5, cells in the SHF do not express cardiomyocyte markers.
Surprisingly, cells in the SHF of the Hoxb1 mutant expressed α-
actinin and MF20, two differentiation markers, before reaching the
OFT (Fig. 3G–J; arrows). We found a 2.5 fold increase in the
number of α-actinin-positive cells in the anterior region of the SHF
(Supplemental Fig. S5), suggesting premature differentiation of
cardiac progenitor cells that normally contribute to the inferior
OFT wall. In order to better visualize this premature differentiation
we generated three-dimensional (3D) reconstructions of MF20-
positive and GFP-positive cells using a Hoxb1GFP allele at E9.5
(Fig. 3K and L; Supplemental Fig. S5). 3D reconstruction was lim-
ited to the pharyngeal region located caudally to the OFT (Sup-
plemental Fig. S5). 3D reconstruction displayed a clear increase of
MF20-expressing cells in the dorsal pericardial wall caudal to the
OFT of the mutants. Overall, these results indicate that Hoxb1 playsan important role in the balance between proliferation and dif-
ferentiation in the pharyngeal region during OFT development.
3.4. Hoxa1 does not affect SHF and OFT morphogenesis
Hoxa1 expression overlaps partially with that of Hoxb1 in the
pSHF (Bertrand et al., 2011). We observed that a fraction of
Hoxa1 / embryos had VSD at E17.5 (Table I), consistent with the
results of Makki and Capecchi, 2012. We investigated whether loss
of Hoxa1 affected OFT morphology at E9.5 and E10.5. We found
that Hoxa1 / embryos exhibited no obvious abnormalities in OFT
morphology at E9.5, as revealed by similar OFT length betweenWT
(n¼4) and Hoxa1 / (n¼4) embryos (Supplemental Fig. S6). Since
Hoxa1 is expressed in precursors of cardiac neural crest cells and is
required for their speciﬁcation (Makki and Capecchi, 2012), we
examined the expression of Crabp1, a marker of migrating neural
crest cells, at E9.5 (Fig. 4A and B). Consistently with previous re-
ports, Hoxa1 / embryos exhibited a strongly reduced, but still
detectable, expression of Crabp1 in the 2nd pharyngeal arch
(Fig. 4A and B). In addition, streams of migrating neural crest cells
appeared disorganized in Hoxa1 / mutants (Fig. 4A and B; ar-
rowheads). To assess whether neural crest-derived cells were
Fig. 4. Neural crest and SHF development inHoxa1embryos. (A) and (B) Whole-mount in situ hybridization for Crabp1 showing migrating cardiac neural crest cells in wild-
type (WT) and Hoxa1 / embryos at E9.5. Yellow and red arrowheads indicate normal and abnormal post-otic streams of migrating neural crest cells, respectively. (C) and
(D) Immunochemistry with anti-AP-2α antibody (red) in transverse sections of E9.5 embryos reveals the presence of neural crest cells-derived mesenchyme in Hoxa1 /
embryos. (E)–(H) Whole-mount in situ hybridization for Isl1 (E) and (F) and Tbx1 (G) and (H) mRNA on E8.75 and E9.5 embryos. Expression of SHF markers appears
unaffected in absence of Hoxa1. (I) and (J) Transverse sections of WT and Hoxa1 / embryos showing normal expression of Fgf8. (K) and (L) Immunochemistry with anti-
phospho-ERK antibody (p-ERK, green) in transverse sections of E9.5 embryos shows no elevated activity of Fgf signaling in Hoxa1 / compared to WT embryos. (M) and
(N) Immunochemistry with anti-p-Smad1/5/8 antibody (p-Smad1, green) do not reveal an elevated activation of BMP signaling in the ventral pharyngeal endoderm of
Hoxa1 / embryos. (O and P) Immunochemistry with anti-MF20 antibody (red) reveals no differentiated cells in the SHF of Hoxa1 / embryos. Nuclei are labeled by DAPI
(blue). ba, branchial arch; dpw, dorsal pericardial wall; L-end; lateral endoderm; mes, pharyngeal mesenchyme; OFT, outﬂow tract; Ph, pharynx; RV, right ventricle; V-end,
ventral pharyngeal endoderm; se, surface ectoderm.
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neural crest cells with an AP-2α antibody. We found, a large
number of AP-2α–positive cells within the pharyngeal region of
Hoxa1 / embryos (Fig. 4C and D; see also asterisk in Fig. 4B).
These observations suggest normal neural crest-derived cell con-
tributions to OFT septation in Hoxa1 / embryos. Next we ex-
amined the expression of SHF markers Isl1 and Tbx1. We found no
major difference in Isl1 and Tbx1 expression in Hoxa1 / embryos
(Fig. 4E–H). Of note, Hoxa1 / embryos exhibited hypoplasia of
the posterior pharyngeal arches. In contrast to Hoxb1 / embryos,Fgf8 expression was normal in the pharyngeal region of Hoxa1 /
embryos (Fig. 4I and J; Supplemental Fig. S7) and this was con-
ﬁrmed by p-ERK labeling analysis (Fig. 4K and L; see Fig. 6E and F
for quantiﬁcation). Immunohistochemistry performed with
p-Smad1 did not reveal dramatic difference between WT and
Hoxa1 / embryos (Fig. 4M and N; see Fig. 6G and H for the
quantiﬁcation). Consistently, MF20 immunostaining revealed no
premature differentiation in the SHF of Hoxa1 / embryos (Fig. 4O
and P). Together these ﬁndings suggest that SHF development is
normal in Hoxa1 / embryos.
Fig. 5. OFT defects in compound Hoxa1;Hoxb1 mutants. (A) and (D) Whole-mount in situ hybridization for Mlc2v at E9.5 in compound Hoxa1; Hoxb1 embryos. Heart
morphology in Hoxa1 /;Hoxb1 / embryos appears abnormal compared to other compound embryos. (E) Histogram showing quantitative measurements of OFT length
fromWT and compound Hoxa1; Hoxb1 hearts at E10.5 using ImageJ. Quantiﬁcation conﬁrms abnormal OFT development in the absence of two copies of Hoxa1 and one copy
of Hoxb1. Histograms are expressed as mean 7SEM. All measures were calculated from n¼3 embryos for each genotype. *po0.05 evaluated by Student’s t test. OFT, outﬂow
tract; LV, left ventricle; RV, right ventricle.
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Since Hoxa1 and Hoxb1 have overlapping expression patterns
and functional redundancy during early development (Gavalas
et al., 1998; Rossel and Capecchi, 1999), we asked whether re-
moving both Hoxa1 and Hoxb1 would exacerbate heart defects
observed in the single mutants. Double Hoxa1þ /; Hoxb1þ /
heterozygous mice were crossed together and a total of 115
fetuses were examined at E17.5. All genotypes, except Hoxa1 /;
Hoxb1 / (3/115 observed vs 7/115 expected), were recovered
according to Mendelian ratios suggesting an early lethality of a
number of double homozygous embryos (po0.05 using Χ2 or
Fisher's test, Supplemental material Table S1 and S2). While no
heart anomalies were observed in single or compound Hoxa1þ /
and Hoxb1þ / heterozygous fetuses, we found that the penetrance
of VSDs was signiﬁcantly increased when one Hoxa1 allele was
removed in Hoxb1 / embryos (Table I; po0.05). Furthermore,
deletion of one or two functional copies of Hoxb1GFP from Hoxa1
mutant homozygotes greatly exacerbated the heart phenotype and
generated DORV, a cardiac defect not seen in single mutant em-
bryo (Table I).
We further examined OFT morphology at E9.5 by whole-mount
ISH and measured OFT length in compound Hoxa1; Hoxb1mutants
(Fig. 5). The OFT length in Hoxa1 / (Supplemental Fig. S6), and
Hoxa1þ /;Hoxb1þ / embryos (Fig. 5) was indistinguishable from
that of WT littermates. Interestingly, signiﬁcant shortening of the
OFT was observed in Hoxa1 /;Hoxb1þ / embryos (Fig. 5), sug-
gesting that deployment of SHF cells is affected in these mutants.
Of note, removal of one supplementary copy of Hoxb1 in this
context did not exacerbate the phenotype compared to Hoxb1 /
mutant embryos alone (Fig. 1K compared to Fig. 5). Taken together,
our results demonstrate that Hoxa1 and Hoxb1 interact genetically
during formation of the cardiac OFT.
3.6. Disruption of pharyngeal signaling in compound Hoxa1 /;
Hoxb1þ / mutants
Since we identiﬁed OFT defects in compound mutants we
further examined the expression of FGF/ERK and BMP/SMAD1
signaling in the pharyngeal region of these embryos.Immunohistochemistry and quantiﬁcation were performed with
p-ERK and p-Smad1 on transverse sections of Hoxa1þ /; Hoxb1þ /
and Hoxa1 /;Hoxb1þ / embryos at E9.5 (Fig. 6A–H). In contrast to
Hoxa1 / embryos (Fig. 4L), we found an excessive number of
p-ERK-positive cells in the pharyngeal region of Hoxa1 /; Hoxb1þ /
 embryos (Fig. 6B,E and F). Importantly, we did not detect elevated
p-ERK-positive cell numbers in Hoxa1þ /; Hoxb1þ / embryos
(Fig. 6A,E and F). Quantiﬁcation of cells positive for p-Smad1
staining revealed no signiﬁcant difference between controls and
compound mutant embryos (Fig. 6D,G and H). Interestingly, MF20-
positive cells were detected in the aSHF of Hoxa1 /;Hoxb1þ /
embryos (Fig. 6J). No ectopic MF20-expressing cells were found in
the dorsal pericardial wall caudal of double heterozygous embryos
(Fig. 6I). Together these data reveal a genetic interaction between
Hoxa1 and Hoxb1 in the regulation of signaling pathways in the SHF
during OFT development.4. Discussion
In this study, we have shown that absence of Hoxb1 causes
abnormal morphology of the cardiac OFT, and subsequent ven-
tricular septal defect (VSD) as well as partially penetrant mis-
alignment of the great vessels.
4.1. Hoxb1 regulates intercellular signaling pathways in the phar-
yngeal region
OFT elongation involves progressive addition of progenitor cells
from the SHF, which requires precise temporal regulation of SHF
cell proliferation and differentiation. Modulation of FGF signaling
in pharyngeal mesoderm of Hoxb1 / embryos was revealed by
elevated p-ERK levels in ventral splanchnic mesoderm located
caudally to the OFT. This increased activation of FGF signaling is
likely to promote the increased cell proliferation observed in the
pharyngeal region of Hoxb1 / embryos. This is consistent with
the role of FGF8 as the major FGF ligand controlling proliferation in
pharyngeal mesoderm and endoderm (Ilagan et al., 2006; Park
et al., 2006; Watanabe et al., 2010).
A precise level of FGF8 signaling has been associated with
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avian SHF. Interestingly, ablation of cardiac neural crest in chicken
embryos causes a functional increase in FGF signaling (Farrell
et al., 2001; Hutson et al., 2006) and increased Fgf8 transcript le-
vels were observed in the caudal pharynx of neural crest-ablated
embryos (Hutson et al., 2006). In addition, ablation of cardiac
neural crest cells leads to misalignment of the OFT with the ven-
tricles, as observed in some Hoxb1 mutant embryos. CardiacFig. 6. FGF/ERK and BMP/SMAD signaling pathways are altered inHoxa1 /;Hoxb1þ /
from Hoxa1þ /; Hoxb1þ / (A,C,I) and Hoxa1 /; Hoxb1þ / (B), (D) and (J) embryos. (A)
increased number of p-ERK positive cells in the ventral pharyngeal endoderm and dorsal
embryos. (C) and (D) Transverse section of Hoxa1þ /;Hoxb1þ / and Hoxa1 /;Hoxb1þ /
robust p-Smad1 expression in the ventral endoderm and the dorsal pericardial wall of H
and p-Smad1-positive cells per section (n¼8) in the pharyngeal endoderm (E) and (G) an
Hoxb1þ / embryos. The quantiﬁcation conﬁrms an increased number of p-ERK-positive c
slight increase of p-Smad1-positive cells in the pharyngeal mesoderm of Hoxa1 /
(J) Immunochemistry with anti-MF20 antibody (red) showing differentiated cells in the
dpw, dorsal pericardial wall; l-end; lateral endoderm; mes, pharyngeal mesenchyme; O
doderm; se, surface ectoderm.defects caused by absence of Hoxb1 are thus similar to those as-
sociated with cardiac neural crest ablation in chick embryos.
Neural crest cells are derived from regions where Hoxb1 is early
expressed as revealed by our previous Cre lineage analysis
using Hoxb1IRES-Cre; R26R mice (Bertrand et al., 2011). However,
Hoxb1 / embryos exhibit no defects in neural crest-derived
tissues (Goddard et al., 1996; Studer et al., 1996), as conﬁrmed here
using AP-2α immunostaining. Although the number of neuralmutants. Immunochemistry on transverse (A)–(D) and sagittal (I) and (J) sections
and (B) Immunochemistry with anti-phospho-ERK antibody (p-ERK, green) reveals
pericardial wall of Hoxa1 /;Hoxb1þ / (arrows) compared to Hoxa1þ /; Hoxb1þ /
 embryos at E9.5 immunostained for phospho-Smad1/5/8 (p-Smad1, red) showing
oxa1 /;Hoxb1þ / embryos. (E)–(H) Histograms comparing the number of p-ERK-
d mesoderm (F) and (H) of E9.5WT, Hoxa1 / , Hoxa1þ /;Hoxb1þ / and Hoxa1 /;
ells in the compound embryos compared to control or Hoxa1 / embryos. Note the
;Hoxb1þ / vs. other genetic backgrounds (*po0.05, Student’s t test). (I) and
SHF of Hoxa1 /;Hoxb1þ / embryos (arrows). Nuclei are labeled with DAPI (blue).
FT, outﬂow tract; Ph, pharynx; RV, right ventricle; V-end, ventral pharyngeal en-
M. Roux et al. / Developmental Biology 406 (2015) 247–258256crest-derived cells is not affected in Hoxb1 / , the interaction with
surrounding pharyngeal cells is probably compromised due to al-
teration of major signaling pathways, including FGF and BMP
signaling.
BMP/SMAD signaling regulates SHF differentiation (Hutson
et al., 2010; Tirosh-Finkel et al., 2010; Wang et al., 2010). In ad-
dition, Bmp4 is required for OFT septation (Liu et al., 2004). Al-
though we did not detect signiﬁcant changes in Bmp4 transcript
levels, we found an increase in the number of p-Smad1-positive
cells in Hoxb1 / embryos, suggesting that another BMP ligands
might be involved in this up-regulation. However, the presence of
p-Smad1 in the nucleus is not necessarily equivalent to BMP-in-
duced transcriptional activity (Faure et al., 2002; Monteiro et al.,
2004). Indeed, Smad6 can recruit transcriptional co-repressor CtBP
to repress Smad1-induced transcription (Lin et al., 2003). Inter-
estingly, another Hox protein, Hoxc8, has been shown to nega-
tively regulate BMP-mediated gene expression through the acti-
vation of Smad6 (Kang et al., 2010). More studies are needed to
further explore whether similar regulatory events occur during
OFT development.
4.2. Abnormal presence of cardiomyocytes in the SHF of Hoxb1 /
and Hoxa1 / ; Hoxb1þ / embryos
We observed the presence of ectopic cardiomyocytes in the
pharyngeal mesoderm within the SHF caudal to the OFT in
Hoxb1 / and Hoxa1 /;Hoxb1þ / embryos. Premature differ-
entiation of SHF cells may have different explanations. (1) The
microenvironment of SHF cells is important for OFT morphogen-
esis. A recent study demonstrated that loss of N-cadherin results
in premature differentiation of SHF progenitor cells (Soh et al.,
2014), (2) Communication between pharyngeal mesoderm and
neural crest cells regulates the differentiation and/or recruitment
of SHF cells into OFT. At E9.5, neural crest cells are in close contact
with both layers. Thus, deﬁcient neural crest cells may send an
abnormal signal to SHF mesodermal cells that promote premature
differentiation of the cardiac progenitors as demonstrated by al-
terations of BMP signaling (Jia et al., 2007). Inversely, abnormal
signals send by either the pharyngeal mesoderm or the endoderm
can affect the neural crest cell behaviors and indirectly the dif-
ferentiation of SHF cells, (3) Perturbation of the temporal sequence
of the OFT movement and SHF differentiation can results in the
abnormal presence of cardiomyocytes in the SHF. This problem
may result from an alteration in SHF cell migration (Rana et al.,
2014). Interestingly in Hoxb1 / , MF20-positive cells are located
in a region of the SHF that normally contributes to OFT myo-
cardium (Waldo et al., 2005b, 2001).
4.3. Loss of Hoxb1 affects the inferior wall of the OFT
The myocardial cells of the OFT contribute to the base of the
great vessels (Bajolle et al., 2006; Waldo et al., 2005b). A previous
study suggested that myocardial differences at the base of the
aorta and pulmonary trunk are preﬁgured in distinct SHF cell
populations (Bajolle et al., 2008). Our genetic tracing analysis
using the Hoxb1IRES-Cre mouse line (Arenkiel et al., 2003) demon-
strated a contribution of Hoxb1-expressing cells in the pSHF to the
inferior wall of the OFT, which subsequently gives rise to sub-
pulmonary myocardium (Bertrand et al., 2011). In addition, two
studies using retrospective clonal analysis and DiI labeling ex-
periments in the mouse support this notion (Dominguez et al.,
2012; Lescroart et al., 2012). Our phenotypic analysis of Hoxb1 /
embryos using y96-Myf5-nlacZ-16 (96–16) transgene reveals de-
creased X-gal positive cells at the inferior wall of the OFT which is
consistent with the lineage studies. Previous work has revealed
loss of this β-galactosidase domain and defective contribution ofthe Hoxb1IRES-Cre lineage to the OFT associated with common ar-
terial trunk in Tbx1 mutant hearts (Rana et al., 2014; Theveniau-
Ruissy et al., 2008). However our results suggest a milder SHF
defect in Hoxb1 / embryos potentially due to functional re-
dundancy with other Hox genes expressed in the pSHF including
Hoxa1 and Hoxa3 (Bertrand et al., 2011).
4.4. Overlapping functions of Hoxa1 and Hoxb1 during OFT
development
Heart defects resulting from loss of function of either Hoxa1 or
Hoxb1 are different. Hoxb1 mutant embryos have a shortened OFT
that subsequently causes misalignment of the OFT and VSD. In
contrast, although a low percentage of VSDs was observed, dis-
ruption of Hoxa1 does not alter SHF deployment or the length of
the OFT. These differences suggest distinct functions of these
paralogous Hox genes during OFT development. However, reduc-
tion of the length of the OFT and increased incidence of heart
defects are observed in compound Hoxa1 /;Hoxb1þ / embryos
compared to Hoxa1 / mutants, demonstrating an overlap in
function between these two genes during OFT formation. Ad-
ditionally, we detected an early disruption of FGF/ERK and BMP/
SMAD signaling in the pharyngeal region of Hoxa1 /; Hoxb1þ /
but not in Hoxa1 / embryos. Hence, removing one copy of Hoxb1
in the Hoxa1 / background uncovers a requirement for Hoxa1 in
cells that normally contribute to OFT development. Synergy be-
tween Hoxa1 and Hoxb1 has already been reported in early pat-
terning of the hindbrain region (Gavalas et al., 1998; Rossel and
Capecchi, 1999; Studer et al., 1998). One of these studies revealed
that Hoxa1 plays a role in activating the Hoxb1 r4-enhancer at
early stages but does not participate in long-term maintenance of
Hoxb1 expression (Studer et al., 1998). However, the expression
pattern of Hoxb1 in the pharyngeal region appears normal in
Hoxa1 mutant embryos at E9.5 (data not shown). In summary, our
study deﬁnes a novel role of Hoxa1 in OFT progenitor cells, re-
vealed only in the absence of Hoxb1.
Hoxa3 is expressed in posterior SHF cells that contribute to the
inferior OFT wall (Bertrand et al., 2011; Diman et al., 2011). Hoxa3
is unlikely to compensate for the loss of both Hoxa1 and Hoxb1
since its expression is more posterior than that of both Hoxa1
and Hoxb1 and Hoxa3 expression is unchanged in Hoxa1 / ,
Hoxb1 /\ embryos (Rossel and Capecchi, 1999). Interestingly,
deletion of the HoxA and HoxB gene clusters in the mouse has
uncovered the requirement of both HoxA and HoxB paralogs dur-
ing heart looping (Soshnikova et al., 2013). Although less affected,
heart morphology in double homozygous Hoxa1; Hoxb1 embryos
appears abnormal embryos appears abnormal (see Fig. 5). To-
gether, these results conﬁrm the importance of these two anterior
Hox genes during heart development. Importantly, these defects
may explain the early lethality observed in this genetic context
(Supplementary material Table S1) (Gavalas et al., 1998; Rossel and
Capecchi, 1999; Studer et al., 1998).
In summary, we have discovered a novel role of anterior Hox
genes in OFT development. OFT defects in both Hoxb1 / or
Hoxa1 /; Hoxb1þ / embryos result in altered levels of FGF and
BMP signaling. This in turn results in abnormal proliferation and
premature differentiation of cardiac progenitors in the SHF caudal
to the OFT. Thus, we hypothesize that mutations of human HOXA1
and HOXB1 may contribute to the pathogenesis of the conotruncal
region in human patients.Acknowledgments
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